Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Orifarm A/S
A/S
Active
Advertising protection
CVR 26058708
Energivej 15, 5260
Odense S
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2001 · 25 years old
38 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Orifarm A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
2.0B
1.5B
1.0B
0.5B
-0.0B
2021: 1.5B
1.5B
2021
2022: 1.4B (-6% vs 2021)
1.4B
-6%
2022
2023: 1.6B (+12% vs 2022)
1.6B
+12%
2023
2024: 1.2B (-22% vs 2023)
1.2B
-22%
2024
2025: 1.2B (-4% vs 2024)
1.2B
-4%
2025
EBITDA
DKK millions
25M
19M
12M
6M
0M
2021: 19M
19M
2021
2022: 18M (-5% vs 2021)
18M
-5%
2022
2023: 20M (+11% vs 2022)
20M
+11%
2023
2024: 20M (0% vs 2023)
20M
0%
2024
2025: 19M (-5% vs 2024)
19M
-5%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
1.174.659
1.223.777
1.575.946
1.404.798
1.493.622
Staff expenses
-4.396
-3.267
-7.494
-2.036
-415
EBITDA
18.622
19.964
20.141
18.119
19.075
Depreciation & amort.
-4.415
-4.669
-4.379
-4.072
-4.979
EBIT
14.207
15.295
15.762
14.047
14.096
Net financials
-1.549
3.706
8.094
-830
-3.076
Profit before tax
12.658
19.001
23.856
13.217
11.020
Tax
2.931
4.136
4.982
3.276
2.830
Net profit
9.727
14.865
18.874
9.941
8.190
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
148.121
150.368
301.842
421.634
195.390
Equity
44.048
53.921
76.256
57.382
47.442
Long-term debt
0
0
0
0
0
Short-term debt
102.063
94.065
223.571
362.313
145.810
Total debt
102.063
94.065
223.571
362.313
145.810
Financial ratios
5-year trend
EBITDA margin
1,6 %
This company
15,8 %
Market median
This company
Market median
90% below market
2021
2025
Equity ratio
29,7 %
This company
38,2 %
Market median
This company
Market median
22% below market
2021
2025
Return on equity
22,1 %
This company
18,4 %
Market median
This company
Market median
20% above market
2021
2025
Net profit margin
0,8 %
This company
8,1 %
Market median
This company
Market median
90% below market
2021
2025
Asset turnover
7,93×
This company
1,12×
Market median
This company
Market median
608% above market
2021
2025
Debt / equity
2,36×
This company
0,62×
Market median
This company
Market median
281% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Orifarm A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
